“A treatment method like intranasal delivery that is easier and more convenient may lead to increased compliance and result in a reduced time to treat an anaphylactic event.”
Preclinical studies of a peanut vaccine have been completed while the company has begun preclinical studies of a milk allergy vaccine and is ready to begin studies of an egg allergy vaccine.